LINAWISE-M Forte

Linawise-M Forte (Linagliptin 5 mg + Metformin HCl 1000 mg) is a powerful anti-diabetic combination formulated with Linagliptin 5 mg and Metformin HCl 1000 mg to help achieve effective blood glucose control in adults with Type 2 diabetes mellitus. This dual-action therapy works by improving insulin response and reducing excess glucose production in the body. This combination of linagliptin (a DPP-4 inhibitor) with metformin (a biguanide) is a daily treatment that enhances insulin secretion, reduces glucose production in the liver, and increases insulin sensitivity, usually taken with meals to minimize side effects. Formulated to support long-term diabetes care, Linawise-M Forte (Linagliptin 5 mg + Metformin HCl 1000 mg) can help patients achieve improved metabolic control when used alongside a balanced diet, regular exercise, and physician-guided treatment plans. 

How does Linawise-M Forte (Linagliptin 5 mg + Metformin HCl 1000 mg) work?

Linagliptin (5 mg)

A Dipeptidyl Peptidase-4 (DPP-4) inhibitor that increases levels of active incretin hormones (GLP-1 and GIP).

Prolongs the action of GLP-1 and GIP, which stimulate insulin release from pancreatic \(\beta \)-cells and reduce glucagon secretion from \(\alpha \)-cells in a glucose-dependent manner. 

Metformin HCl (1000 mg)

A biguanide that primarily works by reducing hepatic glucose production (gluconeogenesis).

Improves peripheral glucose uptake and insulin sensitivity in muscles and adipose tissue.

Favorable cardiovascular and metabolic benefits. 

Clinical Benefits 

Provide effective glycemic control in adults with type 2 diabetes mellitus.

Supports reduction in both fasting and post-meal blood glucose levels.

Helps improve insulin sensitivity and overall metabolic response.

Increase glucose-dependent insulin secretion for better sugar control.

Helps reduce excess glucose production by the liver.

Supports long-term HbA1c management with regular use.

Associated with a lower risk of hypoglycemia compared to some conventional therapies.

Linagliptin-based therapy offers a weight-neutral advantage in many patients.

A convenient fixed-dose combination helps improve patient compliance.

Supports comprehensive diabetes management along with diet, exercise, and lifestyle modification.

Dosage & Administration

Linawise-M Forte (Linagliptin 5 mg + Metformin HCl 1000 mg) should be taken strictly under the guidance of a physician. The dosage may vary depending on the patient’s blood glucose levels, clinical condition, and response to treatment. It is generally recommended to take the tablet with meals to help minimize gastric discomfort associated with metformin therapy. Patients are advised to continue following a healthy diet, regular exercise routine, and overall diabetes management plan while on treatment. Regular monitoring of blood sugar levels and kidney function is also recommended during therapy.

Disclaimer

Linawise-M Forte (Linagliptin 5 mg + Metformin HCl 1000 mg) is to be used only under medical supervision. The information provided is for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Dosage and duration of therapy should be decided by the treating physician based on the patient’s clinical condition. Not indicated for the treatment of Type 1 Diabetes Mellitus or diabetic ketoacidosis.